Showing 1751-1760 of 1861 results for "".
- MELA Sciences Appoints Dr. Darrell Rigel as Chief Medical Advisor to Its Board of Directorshttps://practicaldermatology.com/news/20131001-mela_sciences_appoints_dr_darrell_rigel_as_chief_medical_advisor_to_its_board_of_directors/2459445/MELA Sciences, Inc., announced that Darrell S. Rigel, MD, MS, Clinical Professor of Dermatology at New York University, Langone Medical Center, has been appointed Chief Medical Advisor to the Company's Board of Directors. Dr. Rigel is a Clinical Profes
- Anacor Submits NDA, Presents Data for Tavaborolehttps://practicaldermatology.com/news/20130830-anacor_submits_nda_presents_data_for_tavaborole/2459469/Anacor Pharmaceuticals has submitted an NDA to the FDA for for Tavaborole, its drug candidate for the topical treatment of onychomycosis. The company recently reported data presented at this summer's 2013 APMA Annual Scientific Meeting. Findings s
- Georgia Governor Signs AMA Model Legislationhttps://practicaldermatology.com/news/20130520-georgia_governor_signs_ama_model_legislation/2459538/Georgia lawmakers enacted legal protections for physicians engaged in quality and delivery improvement initiatives included in the federal health care reform law. This first-of-its-kind legislation reinforces the concept that medical decisions are made based on a patient's unique medical needs. The
- SELF Magazine Awards Glytone “Best Night Cream”https://practicaldermatology.com/news/20130516-self_magazine_awards_glytone_best_night_cream/2459542/Glytone won one of SELF Magazine's 14th annual Healthy Beauty Awards, landing the distinction of “Best Night Cream” 2013 for Glytone Anti-aging Night Cream. The publication surveyed more than 1,600 US readers on their favorite beauty products—based on products that deliver on their promise—in five d
- Amgen to Present at ASCOhttps://practicaldermatology.com/news/20130516-amgen_to_present_at_asco/2459543/Amgen will present data from several studies of both pipeline and marketed products at the 2013 American Society of Clinical Oncology Annual Meeting from May 31 to June 4 in Chicago. Abstracts will include study results on talimogene laherparepvec,
- Anterios CEO to Present at Healthcare Conferencehttps://practicaldermatology.com/news/20130429-anterios_ceo_to_present_at_healthcare_conference/2459558/CEO and Founder of Anterios, Inc., Jon Edelson, MD, will be presenting at Needham & Company's 12th Annual Healthcare Conference in New York City on April 30, 2013. In other company news, Anterios also recently received an $8.5 million round of
- Promius Pharma Introduces Zenatane and “The Promius Promise”https://practicaldermatology.com/news/20130412-promius_pharma_introduces_zenatane_and_the_promius_promise/2459565/Promius Pharma, LLC announced the introduction of Zenatane (Isotretinoin) Capsules, a newly approved isotretinoin option for patients with severe, recalcitrant, nodular acne. Zenatane will be supported by The Promius Promise, a pharmacy serv
- World's Most Valuable Cosmetics Brands Revealedhttps://practicaldermatology.com/news/20130410-worlds_most_valuable_cosmetics_brands_revealed/2459566/Brand Finance released its annual study of the top 50 most valuable cosmetics brands. Despite a very slight brand value fall, Olay holds its dominant position at the top of the BrandFinance Cosmetics 50 table, with a value of US$11.7 billion. However, Olay's lead at the top has shrunk from US$4 bill
- “Dermatologist from the Heart” Program Seeks Grant Proposalshttps://practicaldermatology.com/news/20130410-dermatologist_from_the_heart_program_seeks_grant_proposals/2459567/“Dermatologist from the Heart” is a new program from La Roche-Posay that aims to support initiatives designed to enhance the quality of life for patients. The initiative will award a grant to the most compassionate project spearheaded by dermatologists that seek to enhance patients' quality of life.
- Dr. Yates Hair Science Group Adopts ARTAS Systemhttps://practicaldermatology.com/news/20130410-dr_yates_hair_science_group_adopts_artas_system/2459568/Restoration Robotics, Inc. installed its revolutionary ARTAS® System at the Dr. Yates Hair Science Group. The ARTAS System is the first and only FDA-cleared, physician-controlled, computer-assisted technology for hair transplantation.